Editorial
doi: 10.1056/NEJMe1515876.
Von Willebrand Factor--A New Target for TTP Treatment?
Affiliations
- PMID: 26863360
- DOI: 10.1056/NEJMe1515876
Item in Clipboard
Editorial
Von Willebrand Factor--A New Target for TTP Treatment?
N Engl J Med.
.
No abstract available
Comment on
-
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura.N Engl J Med. 2016 Feb 11;374(6):511-22. doi: 10.1056/NEJMoa1505533. N Engl J Med. 2016. PMID: 26863353 Clinical Trial.
Similar articles
-
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura.N Engl J Med. 2016 Jun 23;374(25):2497. doi: 10.1056/NEJMc1603180. N Engl J Med. 2016. PMID: 27332912 No abstract available.
-
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura.N Engl J Med. 2016 Jun 23;374(25):2497-8. doi: 10.1056/NEJMc1603180. N Engl J Med. 2016. PMID: 27332911 No abstract available.
-
Caplacizumab: an anti-von Willebrand factor antibody for the treatment of thrombotic thrombocytopenic purpura.Am J Health Syst Pharm. 2020 Jul 23;77(15):1201-1207. doi: 10.1093/ajhp/zxaa151. Am J Health Syst Pharm. 2020. PMID: 32588878 Review.
-
Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura.N Engl J Med. 2019 Jan 24;380(4):335-346. doi: 10.1056/NEJMoa1806311. Epub 2019 Jan 9. N Engl J Med. 2019. PMID: 30625070 Clinical Trial.
-
Emerging mechanisms to modulate VWF release from endothelial cells.Int J Biochem Cell Biol. 2021 Feb;131:105900. doi: 10.1016/j.biocel.2020.105900. Epub 2020 Dec 7. Int J Biochem Cell Biol. 2021. PMID: 33301925 Review.
Cited by
-
Outcomes in 1096 patients with severe thrombotic thrombocytopenic purpura before the Caplacizumab era.PLoS One. 2021 Aug 12;16(8):e0256024. doi: 10.1371/journal.pone.0256024. eCollection 2021. PLoS One. 2021. PMID: 34383822 Free PMC article.
-
Refractory Auto-Immune Thrombotic Thrombocytopenic Pupura Successfully Treated With Caplacizumab.Front Med (Lausanne). 2020 Oct 22;7:549931. doi: 10.3389/fmed.2020.549931. eCollection 2020. Front Med (Lausanne). 2020. PMID: 33195299 Free PMC article.
-
The Long and Winding Road for New Treatments for Acquired Thrombotic Thrombocytopenic Purpura.Hemasphere. 2019 Jan 23;3(1):e177. doi: 10.1097/HS9.0000000000000177. eCollection 2019 Feb. Hemasphere. 2019. PMID: 31723812 Free PMC article. No abstract available.
-
Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura.Intensive Care Med. 2019 Nov;45(11):1518-1539. doi: 10.1007/s00134-019-05736-5. Epub 2019 Oct 7. Intensive Care Med. 2019. PMID: 31588978
-
A dramatic recovery in a patient initially expected to die of TTP & its complications.J Community Hosp Intern Med Perspect. 2018 Jun 12;8(3):142-144. doi: 10.1080/20009666.2018.1475186. eCollection 2018. J Community Hosp Intern Med Perspect. 2018. PMID: 29915654 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
